Since it is recognized that MM cells are addicted to extracellular glutamine uptake because of poor glutamine synthetase (GS) expression [116], targeting the glutamine metabolism could open alternative therapeutic avenues. This evidence concerns the gene GLUL and Miyoshi myopathy.